Silo Pharma (NASDAQ:SILO) Issues Quarterly Earnings Results

Silo Pharma (NASDAQ:SILO) released its earnings results on Friday. The company reported ($0.41) earnings per share (EPS) for the quarter, Zacks reports. Silo Pharma had a negative net margin of 5,255.05% and a negative return on equity of 61.38%.

Silo Pharma Stock Down 5.3 %

Silo Pharma stock traded down $0.07 during mid-day trading on Friday, hitting $1.25. The company’s stock had a trading volume of 71,341 shares, compared to its average volume of 3,195,740. Silo Pharma has a 52-week low of $0.77 and a 52-week high of $4.50. The firm’s 50 day moving average is $1.52 and its 200 day moving average is $1.24.

Silo Pharma Company Profile

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.